InsidersTradesSigma
Track the CG ONCOLOGY INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.6bn. The latest transaction was disclosed on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JAMES MULAY. The full history is accessible without an account.
Analysts rate CG ONCOLOGY INC Strong Buy (bullish), based on 13 analysts. Average price target: US$91.08.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
CG ONCOLOGY INC is a company focused on developing cancer treatments. It is listed on the XNAS market.